Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center

Table 2 Antimicrobial resistance pattern that predict ESBL phenotype

Predictive drug resistance phenotype	ESBL n (%)		OR (95% CI)	p- value
Predictive drug resistance phenotype	Yes	No
AAGCS
Yes	12 (44.4)	15 (55.6)	3.50 (1.5-8.3)	0.004
No	29 (18.6)	127 (81.4)	1
AAG
Yes	30 (44.8)	37 (55.2)	7.74 (3.5-17.0)	<0.001
No	11(9.48)	105 (90.5)	1
AAC
Yes	14 (43.8)	18 (56.3)	3.57 (1.6-8.1)	0.002
No	27 (17.9)	124 (82.1)	1
GCS
Yes	12 (42.9)	16 (57.1)	3.26 (1.4-7.6)	0.006
No	29 (18.7)	126 (81.3)	1
GC
Yes	12 (42.9)	16 (57.1)	3.26 (1.4-7.6)	0.006
No	29 (18.7)	126 (81.3)	1
GS
Yes	33 (45.8)	39 (54.2)	10.89 (4.6-25.6)	<0.001
No	8 (7.2)	103 (92.8)	1

Note: AAGCS = A- Ampicillin, A- Amoxicillin/Clavulanate, G- Gentamicin, C-Ciprofloxacin, and S- trimethoprim-sulphamethoxazole, AAG = A- Ampicillin, A- Augmentin, G- Gentamicin, AAC = A- Ampicillin, A- Augmentin, C- Ciprofloxacin, GCS = G- Gentamicin, C- Ciprofloxacin, S- trimethoprim-sulphamethoxazole, GC = G- Gentamicin, C- Ciprofloxacin, GS = G- Gentamicin, S- trimethoprim-sulphamethoxazole.

ISSN: 1756-0500